Analysis

Pharma Technology Focus – Issue 61

Pharma Technology Focus – Issue 61

Roundtable: discussing trends in contract manufacturing

Roundtable: discussing trends in contract manufacturing

Brain boosters: exploring the grey area of off-label ‘smart drugs’

Brain boosters: exploring the grey area of off-label ‘smart drugs’

India's drug price overhaul: a question of balance

India's drug price overhaul: a question of balance

Pfizer’s big antibiotic buyout: a sign of things to come?

Pfizer’s big antibiotic buyout: a sign of things to come?

August's top stories: Pfizer-AstraZeneca $1.5bn deal, Cinven buys Bioclinica for $1.4bn

August's top stories: Pfizer-AstraZeneca $1.5bn deal, Cinven buys Bioclinica for $1.4bn

Taking the sting out of painkillers: how close are we to ending the opiate epidemic?

Taking the sting out of painkillers: how close are we to ending the opiate epidemic?

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50

How the pill box is getting smarter

How the pill box is getting smarter

Xilonix: new anti-tumour cancer drug is on the fast-track

Xilonix: new anti-tumour cancer drug is on the fast-track

ChemoFilter: getting the drugs back out

ChemoFilter: getting the drugs back out

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Watching the clock: should day and night influence our drug regimens?

Watching the clock: should day and night influence our drug regimens?

Tackling counterfeit Viagra

Tackling counterfeit Viagra

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals

July's top stories: Cancer Drugs Fund implemented in UK, Nichi-Iko acquired Sagent Pharmaceuticals

The drug company tackling disease in Lebanon’s packed refugee camps

The drug company tackling disease in Lebanon’s packed refugee camps

Nurturing an African pharma boom

Nurturing an African pharma boom

Pharma Technology Focus – Issue 49

Pharma Technology Focus – Issue 49

Health and wealth: the ten biggest pharmaceutical companies by revenue

Health and wealth: the ten biggest pharmaceutical companies by revenue

Blueberries: from superfood to a potential PTSD treatment

Blueberries: from superfood to a potential PTSD treatment

Benign by design: the long road to biodegradable drugs

Benign by design: the long road to biodegradable drugs
cachename:Featurescachekey:rd-137342983_1380709040_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1850298009